Best Practices for Using Cagrilintide Peptide in Clinical and Research Settings To use peptides effectively, you need to know how to handle them, how much to give them, and how to make sure they are safe in both clinical studies and lab research
That is why we go beyond just supplying premium peptides
Further dilutions of the = 1.15 g/ml Nycodenz solution are then made by dilution with a simple isoosmotic diluent such as 132 mM NaCl, 5.4 mM MgSO4, 0.5 mM DTT, 10 mg/ml BSA, 15 mM HEPES-Tris, pH 7.4 [2], or 128 mM NaCl, 5 mM KCl, 4 mg/ml BSA, 0.3 mM Ca/Na-EDTA, 5 mM Tris-HCl, pH 7.4 [8] or sometimes the cell suspension medium is used [7,11]
This contributes to pain reduction in many injury protocols